SCHEMBL9233181

SCHEMBL9233181

C=C(I)C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL11353769 0.68
SCHEMBL8210237 0.67
SCHEMBL11569766 0.67
SCHEMBL21706322 0.67
SCHEMBL270019 0.67
SCHEMBL1889832 0.67
SCHEMBL136969 0.67
SCHEMBL28774597 0.67 TDP1 (0.50)
SCHEMBL3841146 0.64 TDP1 (0.47)
Water SCHEMBL11786429 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115870007-B Composite catalyst for synthesizing propionate by ethylene carbonylation and application method thereof 东南大学 2024-03-15 CN claimed
CN-115870007-A Composite catalyst for synthesizing propionate through ethylene carbonylation and using method thereof 东南大学 2023-03-31 CN claimed
CN-113816955-B RET kinase inhibitor intermediate and preparation method thereof 厦门云凡医药科技有限公司 2022-08-26 CN claimed
CN-113816955-A RET kinase inhibitor intermediate and preparation method thereof 厦门云凡医药科技有限公司 2021-12-21 CN claimed
CN-115870007-B Composite catalyst for synthesizing propionate by ethylene carbonylation and application method thereof 东南大学 2024-03-15 CN disclosed
CN-115870007-A Composite catalyst for synthesizing propionate through ethylene carbonylation and using method thereof 东南大学 2023-03-31 CN disclosed
CN-113816955-B RET kinase inhibitor intermediate and preparation method thereof 厦门云凡医药科技有限公司 2022-08-26 CN disclosed
CN-113816955-A RET kinase inhibitor intermediate and preparation method thereof 厦门云凡医药科技有限公司 2021-12-21 CN disclosed
US-7319100-B2 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-01-15 US disclosed
US-20070155740-A1 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-07-05 US disclosed
US-7238703-B2 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists MERZ PHARMA GMBH & CO. KGAA (DE) 2007-07-03 US disclosed
US-5558803-A ADDITION-CONDENSATION GRAFT COPOLYMERS FOR DIELECTRIC PARTICLES AND INSULATING LIQUIDS NIPPON SHOKUBAI CO., LTD. (JP) 1996-09-24 US disclosed